ID

34386

Descripción

Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver; ODM derived from: https://clinicaltrials.gov/show/NCT01501240

Link

https://clinicaltrials.gov/show/NCT01501240

Palabras clave

  1. 17/1/19 17/1/19 -
  2. 14/5/19 14/5/19 -
Titular de derechos de autor

see on clinicaltrials.gov

Subido en

17 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Liver Cirrhosis NCT01501240

Eligibility Liver Cirrhosis NCT01501240

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
Descripción

ID.1

Tipo de datos

boolean

patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
Descripción

ID.2

Tipo de datos

boolean

Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients under 20 years of age
Descripción

ID.3

Tipo de datos

boolean

patients who have more than 10 nodules detected on hepatobiliary phase of gadoxetic acid-enhanced mr
Descripción

ID.4

Tipo de datos

boolean

patients who underwent transarterial chemotherapy or radiofrequency ablation
Descripción

ID.5

Tipo de datos

boolean

women who are pregnant, lactating or who are of childbearing potential
Descripción

ID.6

Tipo de datos

boolean

patients with any physical or mental status than interferes with the signing of informed consent
Descripción

ID.7

Tipo de datos

boolean

patients with a contraindication for mr
Descripción

ID.8

Tipo de datos

boolean

patients with impaired renal function (e.g. acute renal failure or egfr < 30 ml/min/1.73m2) or patients on dialysis
Descripción

ID.9

Tipo de datos

boolean

Similar models

Eligibility Liver Cirrhosis NCT01501240

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
boolean
ID.2
Item
patients with known liver cirrhosis based on either histology, or a combination of physical examination, laboratory tests, and imaging data
boolean
Item Group
C0680251 (UMLS CUI)
ID.3
Item
patients under 20 years of age
boolean
ID.4
Item
patients who have more than 10 nodules detected on hepatobiliary phase of gadoxetic acid-enhanced mr
boolean
ID.5
Item
patients who underwent transarterial chemotherapy or radiofrequency ablation
boolean
ID.6
Item
women who are pregnant, lactating or who are of childbearing potential
boolean
ID.7
Item
patients with any physical or mental status than interferes with the signing of informed consent
boolean
ID.8
Item
patients with a contraindication for mr
boolean
ID.9
Item
patients with impaired renal function (e.g. acute renal failure or egfr < 30 ml/min/1.73m2) or patients on dialysis
boolean

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial